FDA Orange Book · active-ingredient family
Telaprevir
Telaprevir is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:INCIVEK · NDA 201917
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INCIVEK | VERTEX PHARMS | NDA 201917 | — | May 23, 2011 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8431615 | May 30, 2028 | in 2 yr | U-1398 |
Telaprevir — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
